Digicann Ventures (VY3) 주식 개요는 자회사와 함께 대마초 산업을 운영하고 있습니다. 자세히 보기VY3 펀더멘털 분석스노우플레이크 점수가치 평가0/6미래 성장0/6과거 실적0/6재무 건전성2/6배당0/6강점지난 5년 동안 수입이 매년 70.4% 증가했습니다.위험 분석마이너스 주주 지분의미 있는 시가총액이 없습니다(€75K)지난 3개월 동안 주가 변동성이 German 시장과 비교했을 때 매우 높았습니다.수익이 USD$1m 미만입니다(CA$0)모든 위험 점검 보기VY3 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value€Current Price€0.002해당 없음내재 할인율Est. Revenue$PastFuture-104m15m2016201920222025202620282031Revenue CA$0.002Earnings CA$0.0003AdvancedSet Fair ValueView all narrativesDigicann Ventures Inc. 경쟁사TFF PharmaceuticalsSymbol: MUN:0K30Market cap: €9.7mAvenue TherapeuticsSymbol: OTCPK:ATXIMarket cap: US$1.0mHemo OrganicSymbol: BSE:524590Market cap: ₹77.2mBiofronteraSymbol: XTRA:B8FKMarket cap: €15.6m가격 이력 및 성과Digicann Ventures 주가의 최고가, 최저가 및 변동 요약과거 주가현재 주가CA$0.00252주 최고가CA$0.02852주 최저가CA$0.0005베타2.361개월 변동-50.00%3개월 변동-50.00%1년 변동n/a3년 변동n/a5년 변동-99.90%IPO 이후 변동-99.90%최근 뉴스 및 업데이트공시 • Dec 02Digicann Ventures Inc. Appoints Jordan Fogle as A Director, Effective December 2, 2025Digicann Ventures Inc. announced the appointment of Jordan Fogle as a director of the Company. Jordan's appointment as a member of the board of directors (the "Board") is effective on December 2, 2025 and is subject to all applicable regulatory approvals.공시 • Oct 303WIN Corp. cancelled the acquisition of Digicann Ventures Inc. (CNSX:DCNN) in a reverse merger transaction.3WIN Corp. entered into a letter of intent to acquire Digicann Ventures Inc. (CNSX:DCNN) in a reverse merger transaction for CAD 39.7 million on August 1, 2024. On September 27, 2024, Digicann Ventures entered into a Definitive Agreement for Proposed RTO Transaction with 3Win Corp. Pursuant to the terms of the LOI, the holders of Digicann Shares shall receive a deemed value of CAD 0.05 per share and, upon completion of the Proposed Transaction, 3Win Corp. expects to affect a name change to “Serewin Inc.”. A sub-committee of Digicann’s board of directors (excluding Mr. Kuzyk) determined that the Agreement, including the transactions and other steps contemplated thereunder, is fair to holders of Digicann securities and is in the best interests of the Company. As of January 13, 2025 3Win has elected to postpone the Proposed Transaction to the second quarter of 2025 in order to include its 2024 audited financial results in the disclosures required for listing on the Canadian Securities Exchange. Accordingly, Digicann’s board of directors approved the Agreement and recommends that holders vote their shares in favour of the Proposed Transaction. Completion of the Proposed Transaction is subject to a number of conditions precedent, including but not limited to, the parties entering into a Definitive Agreement, Digicann having a minimum amount of cash at closing of the Proposed Transaction, as well as receipt of all required shareholder, regulatory, and other approvals. Pursuant to the terms of the Definitive Agreement, 3Win shall acquire all the shares of the Company, in the exchange ratio of ninety-eight shares of the Company per one share of 3Win. Upon completion of the Proposed Transaction, the resulting holders of all issued and outstanding shares of 3Win (“3Win Shares”) shall hold approximately 97.3% of the issued and outstanding common shares of the Resulting Issuer (the “Exchange Ratio”), subject to adjustment in certain circumstances and for any additional amounts invested by third parties into 3Win to satisfy any liquidity conditions imposed by the Exchange in connection with the Proposed Transaction. It is also anticipated that all securities convertible, exercisable or exchangeable for 3Win Shares will be converted or exchange (or otherwise become convertible or exercisable in accordance with their terms) into similar securities of the Resulting Issuer on substantially similar terms and conditions based on the Exchange Ratio. All outstanding stock options and common share purchase warrants of the Company are anticipated to remain in effect on substantially the same terms. 3WIN Corp. cancelled the acquisition of Digicann Ventures Inc. (CNSX:DCNN) in a reverse merger transaction on October 29, 2025.공시 • Mar 12Digicann Ventures Inc. announced a financing transactionDigicann Ventures Inc. announced that it has entered into an agreement with the holders of the company to issue 10% Senior Unsecured Convertible Debentures to receive funding on March 12, 2025. The maturity date of the debentures is March 12, 2026.공시 • Aug 043WIN Corp. entered into a letter of intent to acquire Digicann Ventures Inc. (CNSX:DCNN) for CAD 0.22 million.3WIN Corp. entered into a letter of intent to acquire Digicann Ventures Inc. (CNSX:DCNN) for CAD 0.22 million on August 1, 2024. Pursuant to the terms of the LOI, the holders of Digicann Shares shall receive a deemed value of CAD 0.05 per share and, upon completion of the Proposed Transaction3Win Corp. expects to affect a name change to “Serewin Inc.”. Completion of the Proposed Transaction is subject to a number of conditions precedent, including but not limited to, the parties entering into a Definitive Agreement, Digicann having a minimum amount of cash at closing of the Proposed Transaction, as well as receipt of all required shareholder, regulatory, and other approvals.Buy Or Sell Opportunity • Mar 29Now 63% undervaluedThe stock has been flat over the last 90 days, currently trading at €0.0065. The fair value is estimated to be €0.018, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 34% over the last 3 years. Meanwhile, the company became loss making.Buy Or Sell Opportunity • Feb 24Now 86% undervaluedThe stock has been flat over the last 90 days, currently trading at €0.002. The fair value is estimated to be €0.014, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 34% over the last 3 years. Meanwhile, the company became loss making.더 많은 업데이트 보기Recent updates공시 • Dec 02Digicann Ventures Inc. Appoints Jordan Fogle as A Director, Effective December 2, 2025Digicann Ventures Inc. announced the appointment of Jordan Fogle as a director of the Company. Jordan's appointment as a member of the board of directors (the "Board") is effective on December 2, 2025 and is subject to all applicable regulatory approvals.공시 • Oct 303WIN Corp. cancelled the acquisition of Digicann Ventures Inc. (CNSX:DCNN) in a reverse merger transaction.3WIN Corp. entered into a letter of intent to acquire Digicann Ventures Inc. (CNSX:DCNN) in a reverse merger transaction for CAD 39.7 million on August 1, 2024. On September 27, 2024, Digicann Ventures entered into a Definitive Agreement for Proposed RTO Transaction with 3Win Corp. Pursuant to the terms of the LOI, the holders of Digicann Shares shall receive a deemed value of CAD 0.05 per share and, upon completion of the Proposed Transaction, 3Win Corp. expects to affect a name change to “Serewin Inc.”. A sub-committee of Digicann’s board of directors (excluding Mr. Kuzyk) determined that the Agreement, including the transactions and other steps contemplated thereunder, is fair to holders of Digicann securities and is in the best interests of the Company. As of January 13, 2025 3Win has elected to postpone the Proposed Transaction to the second quarter of 2025 in order to include its 2024 audited financial results in the disclosures required for listing on the Canadian Securities Exchange. Accordingly, Digicann’s board of directors approved the Agreement and recommends that holders vote their shares in favour of the Proposed Transaction. Completion of the Proposed Transaction is subject to a number of conditions precedent, including but not limited to, the parties entering into a Definitive Agreement, Digicann having a minimum amount of cash at closing of the Proposed Transaction, as well as receipt of all required shareholder, regulatory, and other approvals. Pursuant to the terms of the Definitive Agreement, 3Win shall acquire all the shares of the Company, in the exchange ratio of ninety-eight shares of the Company per one share of 3Win. Upon completion of the Proposed Transaction, the resulting holders of all issued and outstanding shares of 3Win (“3Win Shares”) shall hold approximately 97.3% of the issued and outstanding common shares of the Resulting Issuer (the “Exchange Ratio”), subject to adjustment in certain circumstances and for any additional amounts invested by third parties into 3Win to satisfy any liquidity conditions imposed by the Exchange in connection with the Proposed Transaction. It is also anticipated that all securities convertible, exercisable or exchangeable for 3Win Shares will be converted or exchange (or otherwise become convertible or exercisable in accordance with their terms) into similar securities of the Resulting Issuer on substantially similar terms and conditions based on the Exchange Ratio. All outstanding stock options and common share purchase warrants of the Company are anticipated to remain in effect on substantially the same terms. 3WIN Corp. cancelled the acquisition of Digicann Ventures Inc. (CNSX:DCNN) in a reverse merger transaction on October 29, 2025.공시 • Mar 12Digicann Ventures Inc. announced a financing transactionDigicann Ventures Inc. announced that it has entered into an agreement with the holders of the company to issue 10% Senior Unsecured Convertible Debentures to receive funding on March 12, 2025. The maturity date of the debentures is March 12, 2026.공시 • Aug 043WIN Corp. entered into a letter of intent to acquire Digicann Ventures Inc. (CNSX:DCNN) for CAD 0.22 million.3WIN Corp. entered into a letter of intent to acquire Digicann Ventures Inc. (CNSX:DCNN) for CAD 0.22 million on August 1, 2024. Pursuant to the terms of the LOI, the holders of Digicann Shares shall receive a deemed value of CAD 0.05 per share and, upon completion of the Proposed Transaction3Win Corp. expects to affect a name change to “Serewin Inc.”. Completion of the Proposed Transaction is subject to a number of conditions precedent, including but not limited to, the parties entering into a Definitive Agreement, Digicann having a minimum amount of cash at closing of the Proposed Transaction, as well as receipt of all required shareholder, regulatory, and other approvals.Buy Or Sell Opportunity • Mar 29Now 63% undervaluedThe stock has been flat over the last 90 days, currently trading at €0.0065. The fair value is estimated to be €0.018, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 34% over the last 3 years. Meanwhile, the company became loss making.Buy Or Sell Opportunity • Feb 24Now 86% undervaluedThe stock has been flat over the last 90 days, currently trading at €0.002. The fair value is estimated to be €0.014, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 34% over the last 3 years. Meanwhile, the company became loss making.Buy Or Sell Opportunity • Feb 01Now 85% undervaluedThe stock has been flat over the last 90 days, currently trading at €0.0005. The fair value is estimated to be €0.0034, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 34% over the last 3 years. Meanwhile, the company became loss making.공시 • Jun 08Agra Ventures Ltd. Appoints Jonathan Hirsh as an Independent Member of the Board of DirectorsAgra Ventures Ltd. announced that Jonathan Hirsh has been appointed as an independent member of the Board of Directors . Best known for his influential work as @Weedstagram416 on the Instagram platform, Jonathan is a globally recognized figure in the cannabis industry, with multiple nominations for the Canadian Cannabis Awards, in both the Influencer of the Year and Cannabis Crusader categories. His impressive portfolio of partnerships comprises over 300 major cannabis-related brands. As a respected voice in the cannabis discourse, Jonathan has journeyed worldwide to judge international cannabis competitions and share his insights at various industry events. Notably, he was among only seven judges invited to participate in the esteemed Jack Herer Cup in Amsterdam. He has also been a guest speaker at CannEx Jamaica in Montego Bay. Jonathan's commitment to cannabis education led him to academia, where he served as a professor of cannabis history at Centennial College. Most recently, he was VP of Marketing and Consumer Experience for Mera Cannabis. There, Jonathan played a pivotal role in developing and launching one of Canada's first legal infused pre-rolls under the Avana and Countryside brands.공시 • Jun 03Agra Ventures Ltd., Annual General Meeting, Jul 21, 2023Agra Ventures Ltd., Annual General Meeting, Jul 21, 2023. Location: Suite 810 789 West Pender Street V6C 1H2 Vancouver British Columbia Canada공시 • Jun 01Agra Ventures Ltd. (CNSX:AGRA) acquired Agraflora Europe Gmbh.Agra Ventures Ltd. (CNSX:AGRA) acquired Agraflora Europe Gmbh on March 31, 2023.Agra Ventures Ltd. (CNSX:AGRA) completed the acquisition of Agraflora Europe Gmbh on March 31, 2023.Board Change • Jul 21Less than half of directors are independentThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 3 new directors. 3 experienced directors. 4 highly experienced directors. 1 independent director (2 non-independent directors). Member of the Advisory Board C. Rebagliati is the most experienced director on the board, commencing their role in 2007. Independent Director Anthony Carnevale was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors.Board Change • Jun 30Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Director Brian O’Neill was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Jun 04First quarter 2022 earnings released: EPS: CA$0.10 (vs CA$0.29 in 1Q 2021)First quarter 2022 results: EPS: CA$0.10 (down from CA$0.29 in 1Q 2021). Net income: CA$1.42m (down 45% from 1Q 2021).Reported Earnings • May 04Full year 2021 earnings released: CA$0.43 loss per share (vs CA$11.79 loss in FY 2020)Full year 2021 results: CA$0.43 loss per share (up from CA$11.79 loss in FY 2020). Net loss: CA$5.10m (loss narrowed 95% from FY 2020).Reported Earnings • Nov 30Third quarter 2021 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2021 results: CA$0.03 loss per share (up from CA$0.50 loss in 3Q 2020). Net loss: CA$359.4k (loss narrowed 93% from 3Q 2020). Revenue was in line with analyst estimates.Reported Earnings • Sep 01Second quarter 2021 earnings released: CA$0.30 loss per share (vs CA$0.77 loss in 2Q 2020)Second quarter 2021 results: Net loss: CA$3.58m (loss narrowed 45% from 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has fallen by 51% per year, which means it is performing significantly worse than earnings.Reported Earnings • Jun 02First quarter 2021 earnings released: EPS CA$0.002 (vs CA$0.009 loss in 1Q 2020)First quarter 2021 results: Net income: CA$2.57m (up CA$11.8m from 1Q 2020). Over the last 3 years on average, earnings per share has fallen by 42% per year whereas the company’s share price has fallen by 47% per year.Reported Earnings • May 05Full year 2020 earnings released: CA$0.079 loss per share (vs CA$0.15 loss in FY 2019)Full year 2020 results: Net loss: CA$102.9m (loss widened 1.9% from FY 2019). Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 40% per year, which means it has not declined as severely as earnings.주주 수익률VY3DE PharmaceuticalsDE 시장7D-88.9%4.9%-2.9%1Yn/a23.4%-0.8%전체 주주 수익률 보기수익률 대 산업: VY3의 German Pharmaceuticals 산업 대비 성과를 판단하기에 데이터가 부족합니다.수익률 대 시장: VY3의 German 시장 대비 성과를 판단하기에 데이터가 부족합니다.주가 변동성Is VY3's price volatile compared to industry and market?VY3 volatilityVY3 Average Weekly Movement130.7%Pharmaceuticals Industry Average Movement6.5%Market Average Movement5.9%10% most volatile stocks in DE Market13.0%10% least volatile stocks in DE Market2.7%안정적인 주가: VY3의 주가는 지난 3개월 동안 German 시장보다 변동성이 컸습니다.시간에 따른 변동성: Insufficient data to determine VY3의 변동성 변화를 판단할 수 없습니다.회사 소개설립직원 수CEO웹사이트2004n/aNick Kuzykwww.digicann.io는 자회사와 함께 대마초 산업을 운영하고 있습니다. 이 회사는 대마초 제품의 생산, 판매 및 유통에 관여합니다. 이 회사는 이전에는 아그라 벤처스 주식회사로 알려졌으며 2023년 8월에 디지캔 벤처스로 사명을 변경했습니다.더 보기Digicann Ventures Inc. 기초 지표 요약Digicann Ventures의 순이익과 매출은 시가총액과 어떻게 비교됩니까?VY3 기초 통계시가총액€74.71k순이익 (TTM)-€243.63k매출 (TTM)n/a0.0x주가매출비율(P/S)-0.3x주가수익비율(P/E)VY3는 고평가되어 있습니까?공정 가치 및 평가 분석 보기순이익 및 매출최근 실적 보고서(TTM)의 주요 수익성 지표VY3 손익계산서 (TTM)매출CA$0매출원가CA$0총이익CA$0기타 비용CA$392.24k순이익-CA$392.24k최근 보고된 실적Mar 31, 2026다음 실적 발표일해당 없음주당순이익(EPS)-0.016총이익률0.00%순이익률0.00%부채/자본 비율-63.3%VY3의 장기 실적은 어땠습니까?과거 실적 및 비교 보기View Valuation기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/09 13:59종가2026/06/09 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Digicann Ventures Inc.는 1명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Siddharth RajeevFundamental Research Corp.
공시 • Dec 02Digicann Ventures Inc. Appoints Jordan Fogle as A Director, Effective December 2, 2025Digicann Ventures Inc. announced the appointment of Jordan Fogle as a director of the Company. Jordan's appointment as a member of the board of directors (the "Board") is effective on December 2, 2025 and is subject to all applicable regulatory approvals.
공시 • Oct 303WIN Corp. cancelled the acquisition of Digicann Ventures Inc. (CNSX:DCNN) in a reverse merger transaction.3WIN Corp. entered into a letter of intent to acquire Digicann Ventures Inc. (CNSX:DCNN) in a reverse merger transaction for CAD 39.7 million on August 1, 2024. On September 27, 2024, Digicann Ventures entered into a Definitive Agreement for Proposed RTO Transaction with 3Win Corp. Pursuant to the terms of the LOI, the holders of Digicann Shares shall receive a deemed value of CAD 0.05 per share and, upon completion of the Proposed Transaction, 3Win Corp. expects to affect a name change to “Serewin Inc.”. A sub-committee of Digicann’s board of directors (excluding Mr. Kuzyk) determined that the Agreement, including the transactions and other steps contemplated thereunder, is fair to holders of Digicann securities and is in the best interests of the Company. As of January 13, 2025 3Win has elected to postpone the Proposed Transaction to the second quarter of 2025 in order to include its 2024 audited financial results in the disclosures required for listing on the Canadian Securities Exchange. Accordingly, Digicann’s board of directors approved the Agreement and recommends that holders vote their shares in favour of the Proposed Transaction. Completion of the Proposed Transaction is subject to a number of conditions precedent, including but not limited to, the parties entering into a Definitive Agreement, Digicann having a minimum amount of cash at closing of the Proposed Transaction, as well as receipt of all required shareholder, regulatory, and other approvals. Pursuant to the terms of the Definitive Agreement, 3Win shall acquire all the shares of the Company, in the exchange ratio of ninety-eight shares of the Company per one share of 3Win. Upon completion of the Proposed Transaction, the resulting holders of all issued and outstanding shares of 3Win (“3Win Shares”) shall hold approximately 97.3% of the issued and outstanding common shares of the Resulting Issuer (the “Exchange Ratio”), subject to adjustment in certain circumstances and for any additional amounts invested by third parties into 3Win to satisfy any liquidity conditions imposed by the Exchange in connection with the Proposed Transaction. It is also anticipated that all securities convertible, exercisable or exchangeable for 3Win Shares will be converted or exchange (or otherwise become convertible or exercisable in accordance with their terms) into similar securities of the Resulting Issuer on substantially similar terms and conditions based on the Exchange Ratio. All outstanding stock options and common share purchase warrants of the Company are anticipated to remain in effect on substantially the same terms. 3WIN Corp. cancelled the acquisition of Digicann Ventures Inc. (CNSX:DCNN) in a reverse merger transaction on October 29, 2025.
공시 • Mar 12Digicann Ventures Inc. announced a financing transactionDigicann Ventures Inc. announced that it has entered into an agreement with the holders of the company to issue 10% Senior Unsecured Convertible Debentures to receive funding on March 12, 2025. The maturity date of the debentures is March 12, 2026.
공시 • Aug 043WIN Corp. entered into a letter of intent to acquire Digicann Ventures Inc. (CNSX:DCNN) for CAD 0.22 million.3WIN Corp. entered into a letter of intent to acquire Digicann Ventures Inc. (CNSX:DCNN) for CAD 0.22 million on August 1, 2024. Pursuant to the terms of the LOI, the holders of Digicann Shares shall receive a deemed value of CAD 0.05 per share and, upon completion of the Proposed Transaction3Win Corp. expects to affect a name change to “Serewin Inc.”. Completion of the Proposed Transaction is subject to a number of conditions precedent, including but not limited to, the parties entering into a Definitive Agreement, Digicann having a minimum amount of cash at closing of the Proposed Transaction, as well as receipt of all required shareholder, regulatory, and other approvals.
Buy Or Sell Opportunity • Mar 29Now 63% undervaluedThe stock has been flat over the last 90 days, currently trading at €0.0065. The fair value is estimated to be €0.018, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 34% over the last 3 years. Meanwhile, the company became loss making.
Buy Or Sell Opportunity • Feb 24Now 86% undervaluedThe stock has been flat over the last 90 days, currently trading at €0.002. The fair value is estimated to be €0.014, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 34% over the last 3 years. Meanwhile, the company became loss making.
공시 • Dec 02Digicann Ventures Inc. Appoints Jordan Fogle as A Director, Effective December 2, 2025Digicann Ventures Inc. announced the appointment of Jordan Fogle as a director of the Company. Jordan's appointment as a member of the board of directors (the "Board") is effective on December 2, 2025 and is subject to all applicable regulatory approvals.
공시 • Oct 303WIN Corp. cancelled the acquisition of Digicann Ventures Inc. (CNSX:DCNN) in a reverse merger transaction.3WIN Corp. entered into a letter of intent to acquire Digicann Ventures Inc. (CNSX:DCNN) in a reverse merger transaction for CAD 39.7 million on August 1, 2024. On September 27, 2024, Digicann Ventures entered into a Definitive Agreement for Proposed RTO Transaction with 3Win Corp. Pursuant to the terms of the LOI, the holders of Digicann Shares shall receive a deemed value of CAD 0.05 per share and, upon completion of the Proposed Transaction, 3Win Corp. expects to affect a name change to “Serewin Inc.”. A sub-committee of Digicann’s board of directors (excluding Mr. Kuzyk) determined that the Agreement, including the transactions and other steps contemplated thereunder, is fair to holders of Digicann securities and is in the best interests of the Company. As of January 13, 2025 3Win has elected to postpone the Proposed Transaction to the second quarter of 2025 in order to include its 2024 audited financial results in the disclosures required for listing on the Canadian Securities Exchange. Accordingly, Digicann’s board of directors approved the Agreement and recommends that holders vote their shares in favour of the Proposed Transaction. Completion of the Proposed Transaction is subject to a number of conditions precedent, including but not limited to, the parties entering into a Definitive Agreement, Digicann having a minimum amount of cash at closing of the Proposed Transaction, as well as receipt of all required shareholder, regulatory, and other approvals. Pursuant to the terms of the Definitive Agreement, 3Win shall acquire all the shares of the Company, in the exchange ratio of ninety-eight shares of the Company per one share of 3Win. Upon completion of the Proposed Transaction, the resulting holders of all issued and outstanding shares of 3Win (“3Win Shares”) shall hold approximately 97.3% of the issued and outstanding common shares of the Resulting Issuer (the “Exchange Ratio”), subject to adjustment in certain circumstances and for any additional amounts invested by third parties into 3Win to satisfy any liquidity conditions imposed by the Exchange in connection with the Proposed Transaction. It is also anticipated that all securities convertible, exercisable or exchangeable for 3Win Shares will be converted or exchange (or otherwise become convertible or exercisable in accordance with their terms) into similar securities of the Resulting Issuer on substantially similar terms and conditions based on the Exchange Ratio. All outstanding stock options and common share purchase warrants of the Company are anticipated to remain in effect on substantially the same terms. 3WIN Corp. cancelled the acquisition of Digicann Ventures Inc. (CNSX:DCNN) in a reverse merger transaction on October 29, 2025.
공시 • Mar 12Digicann Ventures Inc. announced a financing transactionDigicann Ventures Inc. announced that it has entered into an agreement with the holders of the company to issue 10% Senior Unsecured Convertible Debentures to receive funding on March 12, 2025. The maturity date of the debentures is March 12, 2026.
공시 • Aug 043WIN Corp. entered into a letter of intent to acquire Digicann Ventures Inc. (CNSX:DCNN) for CAD 0.22 million.3WIN Corp. entered into a letter of intent to acquire Digicann Ventures Inc. (CNSX:DCNN) for CAD 0.22 million on August 1, 2024. Pursuant to the terms of the LOI, the holders of Digicann Shares shall receive a deemed value of CAD 0.05 per share and, upon completion of the Proposed Transaction3Win Corp. expects to affect a name change to “Serewin Inc.”. Completion of the Proposed Transaction is subject to a number of conditions precedent, including but not limited to, the parties entering into a Definitive Agreement, Digicann having a minimum amount of cash at closing of the Proposed Transaction, as well as receipt of all required shareholder, regulatory, and other approvals.
Buy Or Sell Opportunity • Mar 29Now 63% undervaluedThe stock has been flat over the last 90 days, currently trading at €0.0065. The fair value is estimated to be €0.018, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 34% over the last 3 years. Meanwhile, the company became loss making.
Buy Or Sell Opportunity • Feb 24Now 86% undervaluedThe stock has been flat over the last 90 days, currently trading at €0.002. The fair value is estimated to be €0.014, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 34% over the last 3 years. Meanwhile, the company became loss making.
Buy Or Sell Opportunity • Feb 01Now 85% undervaluedThe stock has been flat over the last 90 days, currently trading at €0.0005. The fair value is estimated to be €0.0034, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 34% over the last 3 years. Meanwhile, the company became loss making.
공시 • Jun 08Agra Ventures Ltd. Appoints Jonathan Hirsh as an Independent Member of the Board of DirectorsAgra Ventures Ltd. announced that Jonathan Hirsh has been appointed as an independent member of the Board of Directors . Best known for his influential work as @Weedstagram416 on the Instagram platform, Jonathan is a globally recognized figure in the cannabis industry, with multiple nominations for the Canadian Cannabis Awards, in both the Influencer of the Year and Cannabis Crusader categories. His impressive portfolio of partnerships comprises over 300 major cannabis-related brands. As a respected voice in the cannabis discourse, Jonathan has journeyed worldwide to judge international cannabis competitions and share his insights at various industry events. Notably, he was among only seven judges invited to participate in the esteemed Jack Herer Cup in Amsterdam. He has also been a guest speaker at CannEx Jamaica in Montego Bay. Jonathan's commitment to cannabis education led him to academia, where he served as a professor of cannabis history at Centennial College. Most recently, he was VP of Marketing and Consumer Experience for Mera Cannabis. There, Jonathan played a pivotal role in developing and launching one of Canada's first legal infused pre-rolls under the Avana and Countryside brands.
공시 • Jun 03Agra Ventures Ltd., Annual General Meeting, Jul 21, 2023Agra Ventures Ltd., Annual General Meeting, Jul 21, 2023. Location: Suite 810 789 West Pender Street V6C 1H2 Vancouver British Columbia Canada
공시 • Jun 01Agra Ventures Ltd. (CNSX:AGRA) acquired Agraflora Europe Gmbh.Agra Ventures Ltd. (CNSX:AGRA) acquired Agraflora Europe Gmbh on March 31, 2023.Agra Ventures Ltd. (CNSX:AGRA) completed the acquisition of Agraflora Europe Gmbh on March 31, 2023.
Board Change • Jul 21Less than half of directors are independentThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 3 new directors. 3 experienced directors. 4 highly experienced directors. 1 independent director (2 non-independent directors). Member of the Advisory Board C. Rebagliati is the most experienced director on the board, commencing their role in 2007. Independent Director Anthony Carnevale was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors.
Board Change • Jun 30Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Director Brian O’Neill was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Jun 04First quarter 2022 earnings released: EPS: CA$0.10 (vs CA$0.29 in 1Q 2021)First quarter 2022 results: EPS: CA$0.10 (down from CA$0.29 in 1Q 2021). Net income: CA$1.42m (down 45% from 1Q 2021).
Reported Earnings • May 04Full year 2021 earnings released: CA$0.43 loss per share (vs CA$11.79 loss in FY 2020)Full year 2021 results: CA$0.43 loss per share (up from CA$11.79 loss in FY 2020). Net loss: CA$5.10m (loss narrowed 95% from FY 2020).
Reported Earnings • Nov 30Third quarter 2021 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2021 results: CA$0.03 loss per share (up from CA$0.50 loss in 3Q 2020). Net loss: CA$359.4k (loss narrowed 93% from 3Q 2020). Revenue was in line with analyst estimates.
Reported Earnings • Sep 01Second quarter 2021 earnings released: CA$0.30 loss per share (vs CA$0.77 loss in 2Q 2020)Second quarter 2021 results: Net loss: CA$3.58m (loss narrowed 45% from 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has fallen by 51% per year, which means it is performing significantly worse than earnings.
Reported Earnings • Jun 02First quarter 2021 earnings released: EPS CA$0.002 (vs CA$0.009 loss in 1Q 2020)First quarter 2021 results: Net income: CA$2.57m (up CA$11.8m from 1Q 2020). Over the last 3 years on average, earnings per share has fallen by 42% per year whereas the company’s share price has fallen by 47% per year.
Reported Earnings • May 05Full year 2020 earnings released: CA$0.079 loss per share (vs CA$0.15 loss in FY 2019)Full year 2020 results: Net loss: CA$102.9m (loss widened 1.9% from FY 2019). Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 40% per year, which means it has not declined as severely as earnings.
